Shandong Fengxiang Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Shandong Fengxiang şirketinin toplam hissedar öz sermayesi CN¥3.1B ve toplam borcu CN¥1.1B olup, bu da borç-öz sermaye oranını 35.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥5.1B ve CN¥2.0B dir. Shandong Fengxiang 'in FAVÖK'ü CN¥223.2M faiz karşılama oranı 3.2 dur. Şirketin CN¥304.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

35.3%

Borç/özkaynak oranı

CN¥1.09b

Borç

Faiz karşılama oranı	3.2x
Nakit	CN¥304.01m
Eşitlik	CN¥3.09b
Toplam yükümlülükler	CN¥1.99b
Toplam varlıklar	CN¥5.08b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Estimating The Fair Value Of Shandong Fengxiang Co., Ltd (HKG:9977)

Jul 15

There Are Reasons To Feel Uneasy About Shandong Fengxiang's (HKG:9977) Returns On Capital

Jun 14

Why We're Not Concerned About Shandong Fengxiang Co., Ltd's (HKG:9977) Share Price

Apr 08

Investors Could Be Concerned With Shandong Fengxiang's (HKG:9977) Returns On Capital

Dec 14

Shandong Fengxiang's (HKG:9977) Earnings Are Growing But Is There More To The Story?

Jan 20

Shandong Fengxiang Co., Ltd's (HKG:9977) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 25

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 9977 'nin kısa vadeli varlıkları ( CN¥1.5B ) kısa vadeli yükümlülüklerini ( CN¥1.5B ) aşıyor.

Uzun Vadeli Yükümlülükler: 9977 şirketinin kısa vadeli varlıkları ( CN¥1.5B ) uzun vadeli yükümlülüklerini ( CN¥533.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 9977 'nin net borç/öz sermaye oranı ( 25.5% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 9977 'nin borç/öz sermaye oranı son 5 yılda 77.5% seviyesinden 35.3% seviyesine düştü.

Borç Kapsamı: 9977 'nin borcu işletme nakit akışı ( 38.1% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 9977 'in borcuna ilişkin faiz ödemeleri EBIT ( 3.2 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Shandong Fengxiang Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Investor sentiment improves as stock rises 28%

Now 32% overvalued

First half 2024 earnings released: EPS: CN¥0.038 (vs CN¥0.06 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.038 (vs CN¥0.06 in 1H 2023)

Shandong Fengxiang Co., Ltd to Report First Half, 2024 Results on Aug 24, 2024

Less than half of directors are independent

Shandong Fengxiang Co., Ltd, Annual General Meeting, May 23, 2024

Shandong Fengxiang Co., Ltd to Report Fiscal Year 2023 Results on Mar 28, 2024

Shandong Fengxiang Co., Ltd has completed a Follow-on Equity Offering in the amount of HKD 276.337558 million.

Shandong Fengxiang Co., Ltd to Report First Half, 2023 Results on Aug 15, 2023

Shandong Fengxiang Co., Lt Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

Shandong Fengxiang Co., Ltd Announces Executive Changes

Less than half of directors are independent

Less than half of directors are independent

Investor sentiment improved over the past week

First half 2022 earnings released: EPS: CN¥0 (vs CN¥0.03 loss in 1H 2021)

Investor sentiment improved over the past week

Shandong Fengxiang Co., Ltd to Report First Half, 2022 Results on Aug 15, 2022

Estimating The Fair Value Of Shandong Fengxiang Co., Ltd (HKG:9977)

There Are Reasons To Feel Uneasy About Shandong Fengxiang's (HKG:9977) Returns On Capital

Shandong Fengxiang Co., Ltd Appoints Ms. Zhou Jinying and Mr. Shi Lei as Executive Directors

Full year 2021 earnings: EPS exceeds analyst expectations

Less than half of directors are independent

Why We're Not Concerned About Shandong Fengxiang Co., Ltd's (HKG:9977) Share Price

Investor sentiment improved over the past week

Shandong Fengxiang Co., Ltd, Annual General Meeting, May 31, 2022

Full year 2021 earnings: Revenues in line with analyst expectations

Shandong Fengxiang Co., Ltd Declares No Final Dividend for Year Ended December 31, 2021

Shandong Fengxiang Co., Ltd Announces Resignation of Directors

Now 24% undervalued after recent price drop

Now 25% undervalued after recent price drop

Investors Could Be Concerned With Shandong Fengxiang's (HKG:9977) Returns On Capital

Joint Company Secretary Pui Wah Siu has left the company

First half 2021 earnings released: CN¥0.03 loss per share (vs CN¥0.15 profit in 1H 2020)

First half 2021 earnings released: CN¥0.03 loss per share (vs CN¥0.14 profit in 1H 2020)

Investor sentiment improved over the past week

Shandong Fengxiang Co., Ltd Approves Final Dividend for the Year Ended 31 December 2020

Full year 2020 earnings released: EPS CN¥0.13 (vs CN¥0.80 in FY 2019)

Chairman of the Board of Supervisors Xiangwei Kong has left the company

Full year 2020 earnings released: EPS CN¥0.13 (vs CN¥0.80 in FY 2019)

Shandong Fengxiang Co., Ltd to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$2.56

Investor sentiment deteriorated over the past week

Shandong Fengxiang's (HKG:9977) Earnings Are Growing But Is There More To The Story?

Investor sentiment improved over the past week

New 90-day high: HK$3.60

Market bids up stock over the past week

Shandong Fengxiang Co., Ltd's (HKG:9977) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Market bids up stock over the past week

Market bids up stock over the past week

Shandong Fengxiang Co., Ltd Announces Company Secretary Changes

Market bids up stock over the past week

Market pulls back on stock over the past week

First half earnings released

First half earnings released

Shandong Fengxiang Co., Ltd to Report First Half, 2020 Results on Aug 31, 2020

Shandong Fengxiang Co., Ltd has completed an IPO in the amount of HKD 1.18215 billion.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin